Oncology Therapeutic Drug Market, Global Outlook and Forecast 2022-2028

July 2022 | 120 pages | ID: OE0EA740348CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Oncology Therapeutic Drug in global, including the following market information:

Global Oncology Therapeutic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Oncology Therapeutic Drug Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Oncology Therapeutic Drug companies in 2021 (%)

The global Oncology Therapeutic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oncology Therapeutic Drug include AbbVie, Amgen, Astellas Pharma, AstraZeneca, Bayer, Biogen, Bristol Myers Squibb, Celgene and Eisai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Therapeutic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncology Therapeutic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oncology Therapeutic Drug Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy
• Others

Global Oncology Therapeutic Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oncology Therapeutic Drug Market Segment Percentages, by Application, 2021 (%)

• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory and Lung Cancer
• Others

Global Oncology Therapeutic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oncology Therapeutic Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oncology Therapeutic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Oncology Therapeutic Drug revenues share in global market, 2021 (%)

Key companies Oncology Therapeutic Drug sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Oncology Therapeutic Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Amgen
• Astellas Pharma
• AstraZeneca
• Bayer
• Biogen
• Bristol Myers Squibb
• Celgene
• Eisai
• Eli Lilly and Company
• Gilead Sciences
• Ipsen
• Johnson and Johnson
• Merck
• Novartis
• Otsuka Pharmaceutical
• Pfizer
• F. Hoffmann-La Roche
• Sanofi
• Takeda Pharmaceutical
• Teva Pharmaceutical Industries

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oncology Therapeutic Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oncology Therapeutic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ONCOLOGY THERAPEUTIC DRUG OVERALL MARKET SIZE

2.1 Global Oncology Therapeutic Drug Market Size: 2021 VS 2028
2.2 Global Oncology Therapeutic Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Oncology Therapeutic Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Oncology Therapeutic Drug Players in Global Market
3.2 Top Global Oncology Therapeutic Drug Companies Ranked by Revenue
3.3 Global Oncology Therapeutic Drug Revenue by Companies
3.4 Global Oncology Therapeutic Drug Sales by Companies
3.5 Global Oncology Therapeutic Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Oncology Therapeutic Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Oncology Therapeutic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology Therapeutic Drug Players in Global Market
  3.8.1 List of Global Tier 1 Oncology Therapeutic Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Oncology Therapeutic Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Oncology Therapeutic Drug Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Targeted Therapy
  4.1.4 Immunotherapy
  4.1.5 Hormonal Therapy
  4.1.6 Others
4.2 By Type - Global Oncology Therapeutic Drug Revenue & Forecasts
  4.2.1 By Type - Global Oncology Therapeutic Drug Revenue, 2017-2022
  4.2.2 By Type - Global Oncology Therapeutic Drug Revenue, 2023-2028
  4.2.3 By Type - Global Oncology Therapeutic Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Oncology Therapeutic Drug Sales & Forecasts
  4.3.1 By Type - Global Oncology Therapeutic Drug Sales, 2017-2022
  4.3.2 By Type - Global Oncology Therapeutic Drug Sales, 2023-2028
  4.3.3 By Type - Global Oncology Therapeutic Drug Sales Market Share, 2017-2028
4.4 By Type - Global Oncology Therapeutic Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oncology Therapeutic Drug Market Size, 2021 & 2028
  5.1.2 Breast Cancer
  5.1.3 Gastrointestinal Cancer
  5.1.4 Prostate Cancer
  5.1.5 Respiratory and Lung Cancer
  5.1.6 Others
5.2 By Application - Global Oncology Therapeutic Drug Revenue & Forecasts
  5.2.1 By Application - Global Oncology Therapeutic Drug Revenue, 2017-2022
  5.2.2 By Application - Global Oncology Therapeutic Drug Revenue, 2023-2028
  5.2.3 By Application - Global Oncology Therapeutic Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Oncology Therapeutic Drug Sales & Forecasts
  5.3.1 By Application - Global Oncology Therapeutic Drug Sales, 2017-2022
  5.3.2 By Application - Global Oncology Therapeutic Drug Sales, 2023-2028
  5.3.3 By Application - Global Oncology Therapeutic Drug Sales Market Share, 2017-2028
5.4 By Application - Global Oncology Therapeutic Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oncology Therapeutic Drug Market Size, 2021 & 2028
6.2 By Region - Global Oncology Therapeutic Drug Revenue & Forecasts
  6.2.1 By Region - Global Oncology Therapeutic Drug Revenue, 2017-2022
  6.2.2 By Region - Global Oncology Therapeutic Drug Revenue, 2023-2028
  6.2.3 By Region - Global Oncology Therapeutic Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Oncology Therapeutic Drug Sales & Forecasts
  6.3.1 By Region - Global Oncology Therapeutic Drug Sales, 2017-2022
  6.3.2 By Region - Global Oncology Therapeutic Drug Sales, 2023-2028
  6.3.3 By Region - Global Oncology Therapeutic Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Oncology Therapeutic Drug Revenue, 2017-2028
  6.4.2 By Country - North America Oncology Therapeutic Drug Sales, 2017-2028
  6.4.3 US Oncology Therapeutic Drug Market Size, 2017-2028
  6.4.4 Canada Oncology Therapeutic Drug Market Size, 2017-2028
  6.4.5 Mexico Oncology Therapeutic Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Oncology Therapeutic Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Oncology Therapeutic Drug Sales, 2017-2028
  6.5.3 Germany Oncology Therapeutic Drug Market Size, 2017-2028
  6.5.4 France Oncology Therapeutic Drug Market Size, 2017-2028
  6.5.5 U.K. Oncology Therapeutic Drug Market Size, 2017-2028
  6.5.6 Italy Oncology Therapeutic Drug Market Size, 2017-2028
  6.5.7 Russia Oncology Therapeutic Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Oncology Therapeutic Drug Market Size, 2017-2028
  6.5.9 Benelux Oncology Therapeutic Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Oncology Therapeutic Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Oncology Therapeutic Drug Sales, 2017-2028
  6.6.3 China Oncology Therapeutic Drug Market Size, 2017-2028
  6.6.4 Japan Oncology Therapeutic Drug Market Size, 2017-2028
  6.6.5 South Korea Oncology Therapeutic Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Oncology Therapeutic Drug Market Size, 2017-2028
  6.6.7 India Oncology Therapeutic Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Oncology Therapeutic Drug Revenue, 2017-2028
  6.7.2 By Country - South America Oncology Therapeutic Drug Sales, 2017-2028
  6.7.3 Brazil Oncology Therapeutic Drug Market Size, 2017-2028
  6.7.4 Argentina Oncology Therapeutic Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Oncology Therapeutic Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Oncology Therapeutic Drug Sales, 2017-2028
  6.8.3 Turkey Oncology Therapeutic Drug Market Size, 2017-2028
  6.8.4 Israel Oncology Therapeutic Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Oncology Therapeutic Drug Market Size, 2017-2028
  6.8.6 UAE Oncology Therapeutic Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Oncology Therapeutic Drug Major Product Offerings
  7.1.4 AbbVie Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.1.5 AbbVie Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Oncology Therapeutic Drug Major Product Offerings
  7.2.4 Amgen Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.2.5 Amgen Key News
7.3 Astellas Pharma
  7.3.1 Astellas Pharma Corporate Summary
  7.3.2 Astellas Pharma Business Overview
  7.3.3 Astellas Pharma Oncology Therapeutic Drug Major Product Offerings
  7.3.4 Astellas Pharma Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.3.5 Astellas Pharma Key News
7.4 AstraZeneca
  7.4.1 AstraZeneca Corporate Summary
  7.4.2 AstraZeneca Business Overview
  7.4.3 AstraZeneca Oncology Therapeutic Drug Major Product Offerings
  7.4.4 AstraZeneca Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.4.5 AstraZeneca Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Oncology Therapeutic Drug Major Product Offerings
  7.5.4 Bayer Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.5.5 Bayer Key News
7.6 Biogen
  7.6.1 Biogen Corporate Summary
  7.6.2 Biogen Business Overview
  7.6.3 Biogen Oncology Therapeutic Drug Major Product Offerings
  7.6.4 Biogen Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.6.5 Biogen Key News
7.7 Bristol Myers Squibb
  7.7.1 Bristol Myers Squibb Corporate Summary
  7.7.2 Bristol Myers Squibb Business Overview
  7.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Major Product Offerings
  7.7.4 Bristol Myers Squibb Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.7.5 Bristol Myers Squibb Key News
7.8 Celgene
  7.8.1 Celgene Corporate Summary
  7.8.2 Celgene Business Overview
  7.8.3 Celgene Oncology Therapeutic Drug Major Product Offerings
  7.8.4 Celgene Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.8.5 Celgene Key News
7.9 Eisai
  7.9.1 Eisai Corporate Summary
  7.9.2 Eisai Business Overview
  7.9.3 Eisai Oncology Therapeutic Drug Major Product Offerings
  7.9.4 Eisai Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.9.5 Eisai Key News
7.10 Eli Lilly and Company
  7.10.1 Eli Lilly and Company Corporate Summary
  7.10.2 Eli Lilly and Company Business Overview
  7.10.3 Eli Lilly and Company Oncology Therapeutic Drug Major Product Offerings
  7.10.4 Eli Lilly and Company Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.10.5 Eli Lilly and Company Key News
7.11 Gilead Sciences
  7.11.1 Gilead Sciences Corporate Summary
  7.11.2 Gilead Sciences Oncology Therapeutic Drug Business Overview
  7.11.3 Gilead Sciences Oncology Therapeutic Drug Major Product Offerings
  7.11.4 Gilead Sciences Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.11.5 Gilead Sciences Key News
7.12 Ipsen
  7.12.1 Ipsen Corporate Summary
  7.12.2 Ipsen Oncology Therapeutic Drug Business Overview
  7.12.3 Ipsen Oncology Therapeutic Drug Major Product Offerings
  7.12.4 Ipsen Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.12.5 Ipsen Key News
7.13 Johnson and Johnson
  7.13.1 Johnson and Johnson Corporate Summary
  7.13.2 Johnson and Johnson Oncology Therapeutic Drug Business Overview
  7.13.3 Johnson and Johnson Oncology Therapeutic Drug Major Product Offerings
  7.13.4 Johnson and Johnson Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.13.5 Johnson and Johnson Key News
7.14 Merck
  7.14.1 Merck Corporate Summary
  7.14.2 Merck Business Overview
  7.14.3 Merck Oncology Therapeutic Drug Major Product Offerings
  7.14.4 Merck Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.14.5 Merck Key News
7.15 Novartis
  7.15.1 Novartis Corporate Summary
  7.15.2 Novartis Business Overview
  7.15.3 Novartis Oncology Therapeutic Drug Major Product Offerings
  7.15.4 Novartis Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.15.5 Novartis Key News
7.16 Otsuka Pharmaceutical
  7.16.1 Otsuka Pharmaceutical Corporate Summary
  7.16.2 Otsuka Pharmaceutical Business Overview
  7.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Major Product Offerings
  7.16.4 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.16.5 Otsuka Pharmaceutical Key News
7.17 Pfizer
  7.17.1 Pfizer Corporate Summary
  7.17.2 Pfizer Business Overview
  7.17.3 Pfizer Oncology Therapeutic Drug Major Product Offerings
  7.17.4 Pfizer Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.17.5 Pfizer Key News
7.18 F. Hoffmann-La Roche
  7.18.1 F. Hoffmann-La Roche Corporate Summary
  7.18.2 F. Hoffmann-La Roche Business Overview
  7.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Major Product Offerings
  7.18.4 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.18.5 F. Hoffmann-La Roche Key News
7.19 Sanofi
  7.19.1 Sanofi Corporate Summary
  7.19.2 Sanofi Business Overview
  7.19.3 Sanofi Oncology Therapeutic Drug Major Product Offerings
  7.19.4 Sanofi Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.19.5 Sanofi Key News
7.20 Takeda Pharmaceutical
  7.20.1 Takeda Pharmaceutical Corporate Summary
  7.20.2 Takeda Pharmaceutical Business Overview
  7.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Major Product Offerings
  7.20.4 Takeda Pharmaceutical Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.20.5 Takeda Pharmaceutical Key News
7.21 Teva Pharmaceutical Industries
  7.21.1 Teva Pharmaceutical Industries Corporate Summary
  7.21.2 Teva Pharmaceutical Industries Business Overview
  7.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Major Product Offerings
  7.21.4 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales and Revenue in Global (2017-2022)
  7.21.5 Teva Pharmaceutical Industries Key News

8 GLOBAL ONCOLOGY THERAPEUTIC DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Oncology Therapeutic Drug Production Capacity, 2017-2028
8.2 Oncology Therapeutic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Oncology Therapeutic Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ONCOLOGY THERAPEUTIC DRUG SUPPLY CHAIN ANALYSIS

10.1 Oncology Therapeutic Drug Industry Value Chain
10.2 Oncology Therapeutic Drug Upstream Market
10.3 Oncology Therapeutic Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Oncology Therapeutic Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Oncology Therapeutic Drug in Global Market
Table 2. Top Oncology Therapeutic Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Oncology Therapeutic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Oncology Therapeutic Drug Revenue Share by Companies, 2017-2022
Table 5. Global Oncology Therapeutic Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global Oncology Therapeutic Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Oncology Therapeutic Drug Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Oncology Therapeutic Drug Product Type
Table 9. List of Global Tier 1 Oncology Therapeutic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Therapeutic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Oncology Therapeutic Drug Sales (K Units), 2017-2022
Table 15. By Type - Global Oncology Therapeutic Drug Sales (K Units), 2023-2028
Table 16. By Application – Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Oncology Therapeutic Drug Sales (K Units), 2017-2022
Table 20. By Application - Global Oncology Therapeutic Drug Sales (K Units), 2023-2028
Table 21. By Region – Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Oncology Therapeutic Drug Sales (K Units), 2017-2022
Table 25. By Region - Global Oncology Therapeutic Drug Sales (K Units), 2023-2028
Table 26. By Country - North America Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Oncology Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Oncology Therapeutic Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America Oncology Therapeutic Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Oncology Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Oncology Therapeutic Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe Oncology Therapeutic Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Oncology Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Oncology Therapeutic Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia Oncology Therapeutic Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Oncology Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Oncology Therapeutic Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America Oncology Therapeutic Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Oncology Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Oncology Therapeutic Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Oncology Therapeutic Drug Sales, (K Units), 2023-2028
Table 46. AbbVie Corporate Summary
Table 47. AbbVie Oncology Therapeutic Drug Product Offerings
Table 48. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Oncology Therapeutic Drug Product Offerings
Table 51. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Astellas Pharma Corporate Summary
Table 53. Astellas Pharma Oncology Therapeutic Drug Product Offerings
Table 54. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. AstraZeneca Corporate Summary
Table 56. AstraZeneca Oncology Therapeutic Drug Product Offerings
Table 57. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Bayer Corporate Summary
Table 59. Bayer Oncology Therapeutic Drug Product Offerings
Table 60. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Biogen Corporate Summary
Table 62. Biogen Oncology Therapeutic Drug Product Offerings
Table 63. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Bristol Myers Squibb Corporate Summary
Table 65. Bristol Myers Squibb Oncology Therapeutic Drug Product Offerings
Table 66. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Celgene Corporate Summary
Table 68. Celgene Oncology Therapeutic Drug Product Offerings
Table 69. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Eisai Corporate Summary
Table 71. Eisai Oncology Therapeutic Drug Product Offerings
Table 72. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Eli Lilly and Company Corporate Summary
Table 74. Eli Lilly and Company Oncology Therapeutic Drug Product Offerings
Table 75. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Gilead Sciences Corporate Summary
Table 77. Gilead Sciences Oncology Therapeutic Drug Product Offerings
Table 78. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Ipsen Corporate Summary
Table 80. Ipsen Oncology Therapeutic Drug Product Offerings
Table 81. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Johnson and Johnson Corporate Summary
Table 83. Johnson and Johnson Oncology Therapeutic Drug Product Offerings
Table 84. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Merck Corporate Summary
Table 86. Merck Oncology Therapeutic Drug Product Offerings
Table 87. Merck Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Novartis Corporate Summary
Table 89. Novartis Oncology Therapeutic Drug Product Offerings
Table 90. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Otsuka Pharmaceutical Corporate Summary
Table 92. Otsuka Pharmaceutical Oncology Therapeutic Drug Product Offerings
Table 93. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Pfizer Corporate Summary
Table 95. Pfizer Oncology Therapeutic Drug Product Offerings
Table 96. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. F. Hoffmann-La Roche Corporate Summary
Table 98. F. Hoffmann-La Roche Oncology Therapeutic Drug Product Offerings
Table 99. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Sanofi Corporate Summary
Table 101. Sanofi Oncology Therapeutic Drug Product Offerings
Table 102. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Takeda Pharmaceutical Corporate Summary
Table 104. Takeda Pharmaceutical Oncology Therapeutic Drug Product Offerings
Table 105. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Teva Pharmaceutical Industries Corporate Summary
Table 107. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Offerings
Table 108. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. Oncology Therapeutic Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 110. Global Oncology Therapeutic Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 111. Global Oncology Therapeutic Drug Production by Region, 2017-2022 (K Units)
Table 112. Global Oncology Therapeutic Drug Production by Region, 2023-2028 (K Units)
Table 113. Oncology Therapeutic Drug Market Opportunities & Trends in Global Market
Table 114. Oncology Therapeutic Drug Market Drivers in Global Market
Table 115. Oncology Therapeutic Drug Market Restraints in Global Market
Table 116. Oncology Therapeutic Drug Raw Materials
Table 117. Oncology Therapeutic Drug Raw Materials Suppliers in Global Market
Table 118. Typical Oncology Therapeutic Drug Downstream
Table 119. Oncology Therapeutic Drug Downstream Clients in Global Market
Table 120. Oncology Therapeutic Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Oncology Therapeutic Drug Segment by Type
Figure 2. Oncology Therapeutic Drug Segment by Application
Figure 3. Global Oncology Therapeutic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oncology Therapeutic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oncology Therapeutic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Oncology Therapeutic Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oncology Therapeutic Drug Revenue in 2021
Figure 9. By Type - Global Oncology Therapeutic Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Oncology Therapeutic Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Oncology Therapeutic Drug Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Oncology Therapeutic Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Oncology Therapeutic Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Oncology Therapeutic Drug Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Oncology Therapeutic Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Oncology Therapeutic Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Oncology Therapeutic Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Oncology Therapeutic Drug Sales Market Share, 2017-2028
Figure 19. US Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Oncology Therapeutic Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Oncology Therapeutic Drug Sales Market Share, 2017-2028
Figure 24. Germany Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Oncology Therapeutic Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Oncology Therapeutic Drug Sales Market Share, 2017-2028
Figure 33. China Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Oncology Therapeutic Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Oncology Therapeutic Drug Sales Market Share, 2017-2028
Figure 40. Brazil Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Oncology Therapeutic Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Oncology Therapeutic Drug Sales Market Share, 2017-2028
Figure 44. Turkey Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Oncology Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Oncology Therapeutic Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Oncology Therapeutic Drug by Region, 2021 VS 2028
Figure 50. Oncology Therapeutic Drug Industry Value Chain
Figure 51. Marketing Channels